HOUSE OF COMMONS OF CANADA
35th PARLIAMENT, 2nd SESSION

EVIDENCE

Standing Committee
on

INDUSTRY

Chairman: David Walker, Lib.

Meeting No. 47

Wednesday, March 5, 1997

ORDER OF THE DAY:

Review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993)

WITNESSES:

Allelix Biopharmaceuticals Inc. / Industrial Biotechnology Association of Canada:

Graham Strachan, President and Chief Executive Officer / Director.

Efamol Research:

Michael Winther, President and Chief Executive Officer.

Industrial Biotechnology Association of Canada:

Joyce Groote, President.

University of Toronto:

Dan Drucker, Physician and Researcher.